Danaher Co. (NYSE:DHR) Shares Sold by Brown Brothers Harriman & Co.

Brown Brothers Harriman & Co. lessened its stake in shares of Danaher Co. (NYSE:DHR) by 0.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 15,000 shares of the conglomerate’s stock after selling 63 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in Danaher were worth $4,170,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Mount Yale Investment Advisors LLC raised its position in shares of Danaher by 84.3% in the 1st quarter. Mount Yale Investment Advisors LLC now owns 1,836 shares of the conglomerate’s stock worth $459,000 after buying an additional 840 shares during the period. Ascent Group LLC increased its stake in Danaher by 7.8% during the first quarter. Ascent Group LLC now owns 1,693 shares of the conglomerate’s stock worth $423,000 after acquiring an additional 123 shares during the last quarter. Waverly Advisors LLC raised its holdings in shares of Danaher by 251.1% in the 1st quarter. Waverly Advisors LLC now owns 8,774 shares of the conglomerate’s stock worth $2,191,000 after purchasing an additional 6,275 shares during the period. Ancora Advisors LLC lifted its stake in shares of Danaher by 4.6% in the 1st quarter. Ancora Advisors LLC now owns 6,898 shares of the conglomerate’s stock valued at $1,723,000 after purchasing an additional 305 shares in the last quarter. Finally, Tidal Investments LLC grew its holdings in shares of Danaher by 14.4% during the 1st quarter. Tidal Investments LLC now owns 52,421 shares of the conglomerate’s stock worth $13,089,000 after purchasing an additional 6,618 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Price Performance

NYSE DHR opened at $237.65 on Tuesday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a 12 month low of $215.68 and a 12 month high of $281.70. The company’s 50 day moving average is $257.38 and its two-hundred day moving average is $259.93. The stock has a market cap of $171.65 billion, a price-to-earnings ratio of 45.35, a PEG ratio of 4.34 and a beta of 0.85.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.02 earnings per share. As a group, research analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. The ex-dividend date was Friday, September 27th. Danaher’s payout ratio is currently 20.61%.

Analysts Set New Price Targets

DHR has been the subject of a number of research reports. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Monday, November 18th. Stifel Nicolaus lifted their price objective on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a research note on Thursday, October 31st. Wells Fargo & Company assumed coverage on Danaher in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 price target on the stock. Finally, KeyCorp upped their price target on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.